BRCA1 interaction with human papillomavirus oncoproteins

Area of Science:

• Oncology
• Molecular Biology
• Virology

Background:

• BRCA1 protein normally suppresses estrogen receptor-alpha (ER-alpha) activity in breast and prostate cancer cells.
• BRCA1's inhibitory effect on ER-alpha is weak in cervical cancer cells, where human papillomavirus (HPV) is prevalent.

Purpose of the Study:

• To investigate the interaction between BRCA1 and HPV oncoproteins E6 and E7.
• To determine if HPV E6 and E7 can alter BRCA1's function in regulating ER-alpha activity.

Main Methods:

• Introduction of HPV E6 or E7 oncogenes into HPV-negative cells.
• In vitro and in vivo interaction studies between E6/E7 oncoproteins and BRCA1.
• Analysis of BRCA1's interaction sites with E6/E7 using point mutations.
• Assessment of E6/E7's effect on BRCA1's inhibition of ER-alpha, c-Myc, and human telomerase reverse transcriptase (hTERT) promoter activity.

Main Results:

• HPV E6 and E7 oncoproteins rescue BRCA1's repression of ER-alpha activity.
• E6 and E7 directly interact with BRCA1 through specific domains, including zinc finger regions.
• E6 and E7 antagonize BRCA1's inhibitory effects on ER-alpha, c-Myc, and hTERT promoter activity.
• The antagonism by E6 and E7 does not involve the degradation of BRCA1.

Conclusions:

• Functional interactions exist between BRCA1 and HPV oncoproteins E6 and E7.
• HPV E6 and E7 can disrupt BRCA1's tumor-suppressive functions, potentially contributing to cervical cancer development.